miR-181a is associated with poor clinical outcome in patients with colorectal cancer treated with EGFR inhibitor
Martin Pichler, Elke Winter, Anna Lena Ress, Thomas Bauernhofer, Armin Gerger, Tobias Kiesslich, Sigurd Lax, Hellmut Samonigg, Gerald Hoefler
Journal of Clinical Pathology Mar 2014, 67 (3) 198-203; DOI: 10.1136/jclinpath-2013-201904